Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2016
As of Mar 31, 2016
Q4 FY2015
As of Dec 31, 2015
Q3 FY2015
As of Sep 30, 2015
Q2 FY2015
As of Jun 30, 2015
Q1 FY2015
As of Mar 31, 2015
Q4 FY2014
As of Dec 31, 2014
Q3 FY2014
As of Sep 30, 2014
Q2 FY2014
As of Jun 30, 2014
Q1 FY2014
As of Mar 31, 2014
Assets
Current assets:
Cash and cash equivalents
Short-term investments
Accounts receivable, net
Prepaid expenses and other current assets
Total current assets
Long-term investments
Property and equipment, net
Other assets
Total assets
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable
Accrued expenses
Deferred revenue
Accrued compensation and benefits
Other current liabilities
Total current liabilities
Deferred revenue
Notes payable
Other liabilities
Total liabilities
Stockholders' equity:
Preferred stock, par value $0.000005 per share - 25,000 shares authorized; none issued and outstanding as of March 31, 2016 and December 31, 2015
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Series C Convertible Preferred Stock
Total preferred stock, par value $0.000005 per share - 25,000 shares authorized; none issued and outstanding as of March 31, 2016 and December 31, 2015
Common stock, par value $0.000005 per share - 500,000 shares authorized; 53,383 and 52,557 shares issued and outstanding as of March 31, 2016 and December 31, 2015,respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders' equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support